Syndax

Syndax

Syndax

Syndax Pharmaceuticals is a late-stage clinical development oncology company focused on overcoming the problem of resistance in cancer therapy.
Founded
2005
Raised
$40.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$4,947,480
Debt financing - 2014
$26,600,000
Venture capital (Series B) - 2013
Domain Associates MPM Capital RusnanoMedInvest +1
Team Size
50+
Employees
Xconomy

East Coast Biotech Roundup: Ribon, Syndax, Aldeyra & More

Health Stock markets